📊 Score Breakdown
Offering Ability
70
Cash Runway
10
Float Risk
75
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($400M, 73% of market cap)
📜 Warrant Exercise
15%
• Warrant overhang: 5.3% of shares outstanding
💹 Market Data
Market Cap$548.15M
Shares Outstanding19.82M
Float7.52M
Cash$226.60M
Debt$2.49M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 15.4% shares (2025Q4 vs prior)
69 institutional holders · 14.91M shares
#1
GILEAD SCIENCES, INC.
4.51M shares
#2
FARALLON CAPITAL MANAGEMENT LLC
2.46M shares
#3
RA CAPITAL MANAGEMENT, L.P.
1.02M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.54M
Days to Cover9.4
% of Float20.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2013
4
INSIDER TRANSACTION
Mar 31, 2026
4
INSIDER TRANSACTION
Mar 31, 2026
4
INSIDER TRANSACTION
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ASMB
📊 ASMB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ASMB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.